Works matching IS 03407004 AND DT 2025 AND VI 74 AND IP 7

Results: 35

Enhancing mesothelin CAR T cell therapy for pancreatic cancer with an oncolytic herpes virus boosting CAR target antigen expression.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 7, p. 1, doi. 10.1007/s00262-025-04039-7

By:

Aboalela, Mona Alhussein;
Abdelmoneim, Mohamed;
Matsumura, Shigeru;
Eissa, Ibrahim Ragab;
Bustos-Villalobos, Itzel;
Sibal, Patricia Angela;
Orikono, Yu;
Takido, Yuhei;
Naoe, Yoshinori;
Kasuya, Hideki

Publication type:

Article

Recombinant antibodies from clonally expanded cancer-associated plasma cells.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 7, p. 1, doi. 10.1007/s00262-025-04045-9

By:

Kim, Wonkyung;
Oh, Ji-Hye;
Park, Chae Won;
Kim, Hyori;
Kang, Young Gwang;
Oh, Da Eun;
Lee, Hee Jin;
Kim, Ji Hun;
Sung, Chang Ohk

Publication type:

Article

KLF12 as a potential biomarker for lateral pelvic lymph node metastases in advanced rectal cancer.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 7, p. 1, doi. 10.1007/s00262-025-03991-8

By:

Xiao, Tianxian;
Wei, Fangze;
Zhou, Sicheng;
Zhao, Fuqiang;
Huang, Fei;
Qian, Liu

Publication type:

Article

Characterization of the aryl hydrocarbon receptor as a potential candidate to improve cancer T cell therapies.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 7, p. 1, doi. 10.1007/s00262-025-04065-5

By:

De Castro, Valentine;
Abdellaoui, Oumaïma;
Dehecq, Barbara;
Ndao, Babacar;
Mercier-Letondal, Patricia;
Dauvé, Alexandra;
Garnache-Ottou, Francine;
Adotévi, Olivier;
Loyon, Romain;
Godet, Yann

Publication type:

Article

Targeted CD47 checkpoint blockade using a mesothelin-directed antibody construct for enhanced solid tumor-specific immunotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 7, p. 1, doi. 10.1007/s00262-025-04032-0

By:

Reischer, Anna;
Leutbecher, Alexandra;
Hiller, Björn;
Perini, Enrico;
White, Kieron;
Hernández-Cáceres, Alejandra;
Schele, Alexandra;
Tast, Benjamin;
Rohrbacher, Lisa;
Winter, Lis;
Czogalla, Bastian;
Mahner, Sven;
Flaswinkel, Heinrich;
Leonhardt, Heinrich;
Wyder, Lorenza;
Wichmann, Christian;
Maenner, Denis;
Trillsch, Fabian;
Kessler, Mirjana;
Hopfner, Karl-Peter

Publication type:

Article

Molecular subtyping dictates therapeutic response to anti-PD-L1 immunotherapy in ES-SCLC.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 7, p. 1, doi. 10.1007/s00262-025-04068-2

By:

Zhang, Qianqian;
Wang, Guoxin;
Yan, Wenjie;
Wang, Dong;
Yin, Jie;
Song, Yong;
Ye, Mingxiang;
Lv, Tangfeng

Publication type:

Article

Molecular mimicry between parasites and cancer: a novel approach for developing cancer vaccines and therapeutic antibodies.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 7, p. 1, doi. 10.1007/s00262-025-04069-1

By:

Eissa, Maha Mohamed;
Allam, Sonia Rifaat Ahmed;
Ismail, Cherine Adel;
Ghazala, Rasha Abdelmawla;
El Skhawy, Nahla;
Ibrahim, Eman Ibrahim El-said

Publication type:

Article

Clinical, immune cell, and genetic features predicting survival and long-term response to first-line chemo-immunotherapy treatment for non-small cell lung cancer.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 7, p. 1, doi. 10.1007/s00262-025-04022-2

By:

Huang, Liling;
Zhu, Haohua;
Dai, Liyuan;
Feng, Yu;
Chen, Xinrui;
Xie, Zucheng;
Hu, Xingsheng;
Liu, Yutao;
Hao, Xuezhi;
Lin, Lin;
Wang, Hongyu;
Zhou, Shengyu;
Yao, Jiarui;
Tang, Le;
Han, Xiaohong;
Shi, Yuankai

Publication type:

Article

Analyses of single-cell RNA sequencing uncover the role of intratumoral Helicobacter pylori in shaping tumor progression and immunity in gastric cancer.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 7, p. 1, doi. 10.1007/s00262-025-04048-6

By:

Xu, Jiao;
Yang, Jin;
Sun, Qi;
Chang, Jingbo;
Wang, Fan

Publication type:

Article

Immunotyping of thyroid cancer for clinical outcomes and implications.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 7, p. 1, doi. 10.1007/s00262-025-04061-9

By:

Xu, Jin;
Luo, Zhen;
Xu, Dayong;
Ke, Mujing;
Tan, Cheng

Publication type:

Article

LAG3 as a marker of immune activation in esophageal squamous carcinoma treated with concurrent chemoradiotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 7, p. 1, doi. 10.1007/s00262-025-04076-2

By:

Zhang, Yuxuan;
Zhou, Zijing;
Rui, Yuanyuan;
Kong, Fanhao;
Guo, Zhoubo;
Zhao, Gang;
Wang, Jun;
Li, Jiacheng;
Zhao, Fangdong;
Huang, Hui;
Fang, Fang;
Zhang, Jiarui;
Zhang, Tian;
Zhang, Wencheng;
Wang, Ping;
Chen, Xi;
Zhen, Peng;
Pang, Qingsong

Publication type:

Article

Impact of rheumatoid factors on the function of therapeutic monoclonals specific for PD-1/PD-L1.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 7, p. 1, doi. 10.1007/s00262-025-04078-0

By:

Hock, Barry D.;
Goddard, Liping;
Dobson, Lachlan J.;
MacPherson, Sean A.;
O’Donnell, John L.;
McKenzie, Judith L.;
McLellan, Alexander D.

Publication type:

Article

Exosomal PD-L1 derived from hypoxia nasopharyngeal carcinoma cell exacerbates CD8+ T cell suppression by promoting PD-L1 upregulation in macrophages.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 7, p. 1, doi. 10.1007/s00262-025-04047-7

By:

Yuan, Xiaofei;
Liu, Xiong;
Jiang, Di;
Zheng, Zijun;
Ma, Xuemin;
Wu, Shuting;
Li, Xiangping;
Lu, Juan;
Fu, Ming

Publication type:

Article

Transarterial chemoembolization combined with tyrosine kinase inhibitors and/or immune checkpoint inhibitors induced hypothyroidism is associated with improved overall survival in hepatocellular carcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 7, p. 1, doi. 10.1007/s00262-025-04073-5

By:

Xu, Shengyuan;
Zheng, Ruipeng;
Sun, Chenghao;
Sa, Ri

Publication type:

Article

Correction: Normalization of tumor vasculature by imiquimod: proposal for a new anticancer therapeutic indication for a TLR7 agonist.

Published in:

2025

By:

Jarosz-Biej, Magdalena;
Czapla, Justyna;
Ciepła, Joanna;
Smolarczyk, Ryszard;
Drzyzga, Alina;
Sprus-Lipka, Dorota;
Pilny, Ewelina;
Matuszczak, Sybilla;
Cichoń, Tomasz

Publication type:

Correction Notice

Chaperonin containing TCP1 subunit 5 as a novel pan-cancer prognostic biomarker for tumor stemness and immunotherapy response: insights from multi-omics data, integrated machine learning, and experimental validation.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 7, p. 1, doi. 10.1007/s00262-025-04071-7

By:

Li, Jiajun;
Xu, Nuo;
Hu, Leyin;
Xu, Jiayue;
Huang, Yifan;
Wang, Deqi;
Chen, Feng;
Wang, Yi;
Jiang, Jiani;
Hong, Yanggang;
Ye, Huajun

Publication type:

Article

Pembrolizumab-axitinib versus nivolumab-cabozantinib as first-line therapy in patients with metastatic renal cell carcinoma: a retrospective real-world comparison (ARON-1)

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 7, p. 1, doi. 10.1007/s00262-025-04043-x

By:

Santoni, Matteo;
Roviello, Giandomenico;
Grande, Enrique;
De Giorgi, Ugo;
Fiala, Ondrej;
Seront, Emmanuel;
Molina-Cerrillo, Javier;
Pichler, Renate;
Myint, Zin W.;
Kucharz, Jakub;
Kanesvaran, Ravindran;
Büttner, Thomas;
Pichler, Martin;
Basso, Umberto;
Kopecky, Jindrich;
Bourlon, Maria T.;
Cerbone, Linda;
Buchler, Tomas;
Pinto, Alvaro;
de Liaño, Alfonso Gómez

Publication type:

Article

Correction: Monitoring peripheral blood data supports the prediction of immunotherapy response in advanced non‑small cell lung cancer based on real‑world data.

Published in:

2025

By:

Ramos‑Guerra, Ana D.;
Farina, Benito;
Pérez, Jaime Rubio;
Vilalta‑Lacarra, Anna;
Zugazagoitia, Jon;
Peces‑Barba, Germán;
Seijo, Luis M.;
Paz‑Ares, Luis;
Gil‑Bazo, Ignacio;
Gómez, Manuel Dómine;
Ledesma‑Carbayo, María J.

Publication type:

Correction Notice

Stabilized iRGD modification enhances NY-ESO-1 TCR-T infiltration in solid tumors and synergizes with PD-1 blockade.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 7, p. 1, doi. 10.1007/s00262-025-04077-1

By:

Wu, Yirong;
Qin, Lanqun;
Wang, Jiayu;
Xie, Ziyao;
Su, Xinyu;
Li, Xiang;
Yang, Yueling;
Huang, Rong;
Zhao, Mengke;
Zhao, Lianjun;
Zou, Zhengyun

Publication type:

Article

Stabilized iRGD modification enhances NY-ESO-1 TCR-T infiltration in solid tumors and synergizes with PD-1 blockade.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 7, p. 1, doi. 10.1007/s00262-025-04077-1

By:

Wu, Yirong;
Qin, Lanqun;
Wang, Jiayu;
Xie, Ziyao;
Su, Xinyu;
Li, Xiang;
Yang, Yueling;
Huang, Rong;
Zhao, Mengke;
Zhao, Lianjun;
Zou, Zhengyun

Publication type:

Article

Inhibition of head and neck squamous cell carcinoma by Bruton’s tyrosine kinase inhibitor ibrutinib is associated with reduction of immunosuppressive T cells.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 7, p. 1, doi. 10.1007/s00262-025-04081-5

By:

Bopp, Anna R.;
Lamenza, Felipe F.;
Upadhaya, Puja;
Ryan, Nathan M.;
Kazmierowicz, Natalie;
Jordanides, Pete P.;
Siddiqui, Arham;
Pracha, Sherefuddin H.;
Roth, Peyton;
Iwenofu, O. Hans;
Oghumu, Steve

Publication type:

Article

Inhibition of head and neck squamous cell carcinoma by Bruton’s tyrosine kinase inhibitor ibrutinib is associated with reduction of immunosuppressive T cells.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 7, p. 1, doi. 10.1007/s00262-025-04081-5

By:

Bopp, Anna R.;
Lamenza, Felipe F.;
Upadhaya, Puja;
Ryan, Nathan M.;
Kazmierowicz, Natalie;
Jordanides, Pete P.;
Siddiqui, Arham;
Pracha, Sherefuddin H.;
Roth, Peyton;
Iwenofu, O. Hans;
Oghumu, Steve

Publication type:

Article

Impact of innate lymphoid cell type 2 in chronic lymphocytic leukemia on the function of treg and CD8+ T cells through IL-9.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 7, p. 1, doi. 10.1007/s00262-025-04082-4

By:

Yang, Ruixue;
Zeng, Xuejiao;
Alimu, Xierenguli;
Qu, Jianhua

Publication type:

Article

Impact of innate lymphoid cell type 2 in chronic lymphocytic leukemia on the function of treg and CD8+ T cells through IL-9.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 7, p. 1, doi. 10.1007/s00262-025-04082-4

By:

Yang, Ruixue;
Zeng, Xuejiao;
Alimu, Xierenguli;
Qu, Jianhua

Publication type:

Article

Prognostic significance of osteosarcopenia and its effects on immune response in patients with stage II/III gastric cancer.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 7, p. 1, doi. 10.1007/s00262-025-04084-2

By:

Hirase, Yuki;
Arigami, Takaaki;
Matsushita, Daisuke;
Shimonosono, Masataka;
Tsuruda, Yusuke;
Sasaki, Ken;
Baba, Kenji;
Kawasaki, Yota;
Ohtsuka, Takao

Publication type:

Article

Prognostic significance of osteosarcopenia and its effects on immune response in patients with stage II/III gastric cancer.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 7, p. 1, doi. 10.1007/s00262-025-04084-2

By:

Hirase, Yuki;
Arigami, Takaaki;
Matsushita, Daisuke;
Shimonosono, Masataka;
Tsuruda, Yusuke;
Sasaki, Ken;
Baba, Kenji;
Kawasaki, Yota;
Ohtsuka, Takao

Publication type:

Article

Efficacy and safety of local–regional therapy combined with chemotherapy, immune checkpoint inhibitors and lenvatinib as first-line treatment in advanced intrahepatic cholangiocarcinoma: a multicenter retrospective cohort study.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 7, p. 1, doi. 10.1007/s00262-025-04085-1

By:

Li, Shuofeng;
Yu, Guanhua;
Wang, Mingming;
Feng, Shi;
Wang, Shanshan;
Piao, Mingjian;
Li, Chengjie;
Zhou, Zixiang;
Xun, Ziyu;
Sun, Boyu;
Li, Jiongyuan;
Zhang, Nan;
Li, Hu;
Yang, Xiaobo;
Zhu, Zhenyu;
Zhao, Haitao

Publication type:

Article

Efficacy and safety of local–regional therapy combined with chemotherapy, immune checkpoint inhibitors and lenvatinib as first-line treatment in advanced intrahepatic cholangiocarcinoma: a multicenter retrospective cohort study.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 7, p. 1, doi. 10.1007/s00262-025-04085-1

By:

Li, Shuofeng;
Yu, Guanhua;
Wang, Mingming;
Feng, Shi;
Wang, Shanshan;
Piao, Mingjian;
Li, Chengjie;
Zhou, Zixiang;
Xun, Ziyu;
Sun, Boyu;
Li, Jiongyuan;
Zhang, Nan;
Li, Hu;
Yang, Xiaobo;
Zhu, Zhenyu;
Zhao, Haitao

Publication type:

Article

Osteosarcoma cell–derived CCL2 facilitates lung metastasis via accumulation of tumor-associated macrophages.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 7, p. 1, doi. 10.1007/s00262-025-04051-x

By:

Kondo, Hiroya;
Tazawa, Hiroshi;
Fujiwara, Tomohiro;
Yoshida, Aki;
Kure, Miho;
Demiya, Koji;
Kanaya, Nobuhiko;
Hata, Toshiaki;
Uotani, Koji;
Hasei, Joe;
Kunisada, Toshiyuki;
Kagawa, Shunsuke;
Yoshioka, Yusuke;
Ozaki, Toshifumi;
Fujiwara, Toshiyoshi

Publication type:

Article

The combination of SH003 and DTX induces cytotoxic cell infiltration in anti-PD1 resistant lung cancer.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 7, p. 1, doi. 10.1007/s00262-025-04064-6

By:

Choi, Yu-Jeong;
Lee, Sang-Eun;
Kim, Daeun;
Lim, Hae-In;
Choi, Da Kyung;
Park, Bong Kyu;
Jeon, Chan-Yong;
Ko, Seong-Gyu

Publication type:

Article

Knockdown NEK7 stimulates anti-tumor immune responses by NLRP3/PD-L1 signaling in esophageal cancer.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 7, p. 1, doi. 10.1007/s00262-025-04057-5

By:

Wang, Li;
Cheng, Yurong;
Li, Weiqiang;
Wang, Jing;
Liu, Zhe;
Xiang, Yaoxian;
Liu, Xin;
Wang, Kangjie;
Yan, Dong

Publication type:

Article

Clinical characteristics, outcomes, and predictive modeling of patients diagnosed with immune checkpoint inhibitor therapy-related pneumonitis.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 7, p. 1, doi. 10.1007/s00262-025-04053-9

By:

Hazim, Antonious;
Guiance, Irene Riestra;
Shreve, Jacob;
Ruan, Gordon;
McGlothlin, Damian;
LeMahieu, Allison;
Haemmerle, Robert;
Mcconn, Keith;
Godby, Richard C.;
Kottschade, Lisa;
Schwecke, Anna;
Fazer-Posorske, Casey;
Peikert, Tobias;
Edell, Eric;
Leventakos, Konstantinos;
Egan, Ashley

Publication type:

Article

Extracellular PKM2 modulates cancer immunity by regulating macrophage polarity.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 7, p. 1, doi. 10.1007/s00262-025-04050-y

By:

Peng, Guangda;
Li, Bin;
Han, Hongwei;
Yuan, Yi;
Mishra, Falguni;
Huang, Yang;
Liu, Zhi-Ren

Publication type:

Article

HIF-PH inhibitors induce pseudohypoxia in T cells and suppress the growth of microsatellite stable colorectal cancer by enhancing antitumor immune responses.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 7, p. 1, doi. 10.1007/s00262-025-04067-3

By:

Chen, Yuehua;
Ohara, Toshiaki;
Hamada, Yusuke;
Wang, Yuze;
Tian, Miao;
Noma, Kazuhiro;
Tazawa, Hiroshi;
Fujisawa, Masayoshi;
Yoshimura, Teizo;
Matsukawa, Akihiro

Publication type:

Article

Pembrolizumab plus Lenvatinib in patients with metastatic Renal Cell Carcinoma: real-world evidences from the international ARON- 1 study.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 7, p. 1, doi. 10.1007/s00262-025-04019-x

By:

Porta, Camillo;
Massari, Francesco;
Taha, Tarek;
Grande, Enrique;
Bourlon, Maria T.;
Kanesvaran, Ravindran;
Basso, Umberto;
Molina-Cerrillo, Javier;
Alonso-Gordoa, Teresa;
Myint, Zin W.;
Fornarini, Giuseppe;
Buttner, Thomas;
Park, Se Hoon;
Ürün, Yüksel;
De Giorgi, Ugo;
Pichler, Renate;
Rescigno, Pasquale;
Buchler, Tomas;
Studentova, Hana;
Melichar, Bohuslav

Publication type:

Article

Works matching IS 03407004 AND DT 2025 AND VI 74 AND IP 7

Enhancing mesothelin CAR T cell therapy for pancreatic cancer with an oncolytic herpes virus boosting CAR target antigen expression.

Recombinant antibodies from clonally expanded cancer-associated plasma cells.

KLF12 as a potential biomarker for lateral pelvic lymph node metastases in advanced rectal cancer.

Characterization of the aryl hydrocarbon receptor as a potential candidate to improve cancer T cell therapies.

Targeted CD47 checkpoint blockade using a mesothelin-directed antibody construct for enhanced solid tumor-specific immunotherapy.

Molecular subtyping dictates therapeutic response to anti-PD-L1 immunotherapy in ES-SCLC.

Molecular mimicry between parasites and cancer: a novel approach for developing cancer vaccines and therapeutic antibodies.

Clinical, immune cell, and genetic features predicting survival and long-term response to first-line chemo-immunotherapy treatment for non-small cell lung cancer.

Analyses of single-cell RNA sequencing uncover the role of intratumoral Helicobacter pylori in shaping tumor progression and immunity in gastric cancer.

Immunotyping of thyroid cancer for clinical outcomes and implications.

LAG3 as a marker of immune activation in esophageal squamous carcinoma treated with concurrent chemoradiotherapy.

Impact of rheumatoid factors on the function of therapeutic monoclonals specific for PD-1/PD-L1.

Exosomal PD-L1 derived from hypoxia nasopharyngeal carcinoma cell exacerbates CD8<sup>+</sup> T cell suppression by promoting PD-L1 upregulation in macrophages.

Transarterial chemoembolization combined with tyrosine kinase inhibitors and/or immune checkpoint inhibitors induced hypothyroidism is associated with improved overall survival in hepatocellular carcinoma.

Correction: Normalization of tumor vasculature by imiquimod: proposal for a new anticancer therapeutic indication for a TLR7 agonist.

Chaperonin containing TCP1 subunit 5 as a novel pan-cancer prognostic biomarker for tumor stemness and immunotherapy response: insights from multi-omics data, integrated machine learning, and experimental validation.

Pembrolizumab-axitinib versus nivolumab-cabozantinib as first-line therapy in patients with metastatic renal cell carcinoma: a retrospective real-world comparison (ARON-1)

Correction: Monitoring peripheral blood data supports the prediction of immunotherapy response in advanced non‑small cell lung cancer based on real‑world data.

Stabilized iRGD modification enhances NY-ESO-1 TCR-T infiltration in solid tumors and synergizes with PD-1 blockade.

Stabilized iRGD modification enhances NY-ESO-1 TCR-T infiltration in solid tumors and synergizes with PD-1 blockade.

Inhibition of head and neck squamous cell carcinoma by Bruton’s tyrosine kinase inhibitor ibrutinib is associated with reduction of immunosuppressive T cells.

Inhibition of head and neck squamous cell carcinoma by Bruton’s tyrosine kinase inhibitor ibrutinib is associated with reduction of immunosuppressive T cells.

Impact of innate lymphoid cell type 2 in chronic lymphocytic leukemia on the function of treg and CD8<sup>+</sup> T cells through IL-9.

Impact of innate lymphoid cell type 2 in chronic lymphocytic leukemia on the function of treg and CD8<sup>+</sup> T cells through IL-9.

Prognostic significance of osteosarcopenia and its effects on immune response in patients with stage II/III gastric cancer.

Prognostic significance of osteosarcopenia and its effects on immune response in patients with stage II/III gastric cancer.

Efficacy and safety of local–regional therapy combined with chemotherapy, immune checkpoint inhibitors and lenvatinib as first-line treatment in advanced intrahepatic cholangiocarcinoma: a multicenter retrospective cohort study.

Efficacy and safety of local–regional therapy combined with chemotherapy, immune checkpoint inhibitors and lenvatinib as first-line treatment in advanced intrahepatic cholangiocarcinoma: a multicenter retrospective cohort study.

Osteosarcoma cell–derived CCL2 facilitates lung metastasis via accumulation of tumor-associated macrophages.

The combination of SH003 and DTX induces cytotoxic cell infiltration in anti-PD1 resistant lung cancer.

Knockdown NEK7 stimulates anti-tumor immune responses by NLRP3/PD-L1 signaling in esophageal cancer.

Clinical characteristics, outcomes, and predictive modeling of patients diagnosed with immune checkpoint inhibitor therapy-related pneumonitis.

Extracellular PKM2 modulates cancer immunity by regulating macrophage polarity.

HIF-PH inhibitors induce pseudohypoxia in T cells and suppress the growth of microsatellite stable colorectal cancer by enhancing antitumor immune responses.

Pembrolizumab plus Lenvatinib in patients with metastatic Renal Cell Carcinoma: real-world evidences from the international ARON- 1 study.